Allied Corp. (OTC Pink: ALID) ("Allied") - an international medical cannabis company focused on creating and providing targeted cannabinoid health solutions, is pleased to announce:
- ICA approval: Allied has successfully received the approval from ICA to begin the seed evaluation process
- Successful registration of genetics: Allied has successfully registered twenty-four (24) varieties of strains positioned for production
- Current state of licensing: a report regarding Allied licensing
- The Allied land consideration: The Allied Colombian land mass and cultivation area description
Production
The seed evaluation process in Colombia is very lengthy and extensive. It takes up to five months of regulated field trials, including thorough data collection and analysis, prior to approval for registration for commercial cultivation. The process from beginning to completion can last several years. Allied Corp. has completed the regulatory process and received strain approval from the technical directorate of the ICA (Colombian Institute of Agriculture), representing a diverse range of chemotypes, with various ratios of CBD to THC. "With this approval, our strains can then be registered for commercial production," the team with the company says. "The registration of these 24 strains, including our proprietary strains, is a very big milestone for Allied Corp. These approvals evidence the value of our proprietary stabilized seed bank and our capacity to meet local and global market needs easily. Allied has received the approval to begin the seed evaluation process with ICA. We are anticipating imminent approvals for non-psycho active seed evaluation planting. As well, Allied anticipates a near term approval for psycho-active seed planting."
Licensing
Allied has acquired a full suite of licenses in Colombia. Two of the licenses enables Allied to produce cannabis and cannabis derivatives, grow non-psychoactive cannabis (<1% THC), and grow psychoactive cannabis (>1% THC). The third license that Allied has is the extraction and formulation license. This enables Allied to extract cannabinoids from dried flower. Allied is also awaiting final approval of their Canadian Production License from Health Canada. This license has been given the "confirmation of readiness" notice from Health Canada.
Land
Allied has secured vast agricultural land extension in Ibagué, a key production farming region of Colombia. "Ibague has the benefit of having 12 hours of sunlight year-round, temperatures oscillating between 20-30 degrees celsius, with constant humidity. This environment and situation ideal to growing cannabis at low cost. The land has an area of 1,400 hectares (about 3,450 acres), all with water rights, an electrical substation, and great paved access to the property."
For more information:
Allied Corp
1405 St. Paul Street, #201
Kelowna, BC V1Y 2E4 Canada
Phone: 1-877-255-4337
info@allied.health
allied.health